These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10661519)

  • 21. Elevated NMDA receptors in parkinsonian striatum.
    Weihmuller FB; Ulas J; Nguyen L; Cotman CW; Marshall JF
    Neuroreport; 1992 Nov; 3(11):977-80. PubMed ID: 1482768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
    Suzuki M; Desmond TJ; Albin RL; Frey KA
    Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Striatal dopaminergic abnormalities in human cocaine users.
    Little KY; Zhang L; Desmond T; Frey KA; Dalack GW; Cassin BJ
    Am J Psychiatry; 1999 Feb; 156(2):238-45. PubMed ID: 9989560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Baldwin RM; Zoghbi S; Zea-Ponce Y; Charney DS; van Dyck CH; Hoffer PB; Innis RB
    J Nucl Med; 1997 Sep; 38(9):1453-9. PubMed ID: 9293807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rat model of striatonigral degeneration generated by simultaneous injection of 6-hydroxydopamine into the medial forebrain bundle and quinolinic acid into the striatum.
    Yoon HH; Kim YH; Shin ES; Jeon SR
    J Korean Med Sci; 2014 Nov; 29(11):1555-61. PubMed ID: 25408589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single photon emission computed tomography imaging of dopaminergic function: presynaptic transporter, postsynaptic receptor, and "intrasynaptic" transmitter.
    Innis RB
    Adv Pharmacol; 1998; 42():215-9. PubMed ID: 9327882
    [No Abstract]   [Full Text] [Related]  

  • 27. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.
    Booij J; Tissingh G; Boer GJ; Speelman JD; Stoof JC; Janssen AG; Wolters EC; van Royen EA
    J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):133-40. PubMed ID: 9048712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of cerebral ischemia on dopamine receptors in the gerbil striatum.
    Araki T; Kato H; Shuto K; Fujiwara T; Kogure K; Itoyama Y
    Eur J Pharmacol; 1996 Jun; 306(1-3):73-9. PubMed ID: 8813617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine receptors and transporters in Parkinson's disease and schizophrenia.
    Seeman P; Niznik HB
    FASEB J; 1990 Jul; 4(10):2737-44. PubMed ID: 2197154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
    Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
    Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ketamine decreased striatal [(11)C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: multiparametric PET studies combined with microdialysis analysis.
    Tsukada H; Harada N; Nishiyama S; Ohba H; Sato K; Fukumoto D; Kakiuchi T
    Synapse; 2000 Aug; 37(2):95-103. PubMed ID: 10881030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional and temporal expression of the peripheral benzodiazepine receptor in MPTP neurotoxicity.
    Kuhlmann AC; Guilarte TR
    Toxicol Sci; 1999 Mar; 48(1):107-16. PubMed ID: 10330690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease.
    Araujo DM; Cherry SR; Tatsukawa KJ; Toyokuni T; Kornblum HI
    Exp Neurol; 2000 Dec; 166(2):287-97. PubMed ID: 11085894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopa resistance in multiple-system atrophy: loss of postsynaptic D2 receptors.
    Churchyard A; Donnan GA; Hughes A; Howells DW; Woodhouse D; Wong JY; Kalnins RM; Mendelsohn FA; Paxinos G
    Ann Neurol; 1993 Aug; 34(2):219-26. PubMed ID: 8338346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term methamphetamine-induced decreases of [(11)C]WIN 35,428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey.
    Melega WP; Lacan G; Desalles AA; Phelps ME
    Synapse; 2000 Mar; 35(4):243-9. PubMed ID: 10657033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease.
    Innis RB; Seibyl JP; Scanley BE; Laruelle M; Abi-Dargham A; Wallace E; Baldwin RM; Zea-Ponce Y; Zoghbi S; Wang S
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11965-9. PubMed ID: 8265656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine transporter development in postnatal rat striatum: an autoradiographic study with [3H]WIN 35,428.
    Coulter CL; Happe HK; Murrin LC
    Brain Res Dev Brain Res; 1997 Dec; 104(1-2):55-62. PubMed ID: 9466707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters.
    Fischman AJ; Bonab AA; Babich JW; Palmer EP; Alpert NM; Elmaleh DR; Callahan RJ; Barrow SA; Graham W; Meltzer PC; Hanson RN; Madras BK
    Synapse; 1998 Jun; 29(2):128-41. PubMed ID: 9593103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time course of changes in striatal dopamine transporters and D2 receptors with specific iodinated markers in a rat model of Parkinson's disease.
    Chalon S; Emond P; Bodard S; Vilar MP; Thiercelin C; Besnard JC; Guilloteau D
    Synapse; 1999 Feb; 31(2):134-9. PubMed ID: 10024010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.